{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:43:34Z","timestamp":1778255014153,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The National Accreditation Program of Breast Centers (NAPBC) developed comprehensive, multidisciplinary standards to improve quality outcomes. We have previously shown that institutions treating larger proportions of breast cancer patients of low socioeconomic status (SES) achieve these benchmarks at lower rates. This study assesses whether a patient\u2019s SES interacts with an institution\u2019s SES mix in achieving the 2018 NAPBC standards.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using the National Cancer Database, low SES patients were defined by insurance status, income and educational attainment, and low SES institutions were defined as the decile containing the largest proportion of low SES patients. Cohorts were created for each measurable NAPBC standard: breast-conserving surgery, sentinel lymphadenectomy, adjuvant radiation, adjuvant chemotherapy, and adjuvant endocrine therapy. Adjusted odds of standard-compliant treatment (SCT) were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 3,156,604 patients (23% being low SES) treated at 1180 non-low SES institutions and 283,155 patients (59% being low SES) treated at 131 low SES institutions. All subgroups reached the 50% threshold for breast-conserving surgery, with rates of SCT &gt; 70% for all other standards. Both low SES institution and low SES patient status were independently associated with a lower probability of SCT for all standards (<jats:italic>p<\/jats:italic> &lt; 0.001), except there was no association between institution type and receiving adjuvant radiation (<jats:italic>p<\/jats:italic> = 0.21).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Patient and institution SES impact the achievement of NAPBC standards; low SES patients received lower SCT regardless of institution SES. Further work to create strategies that address SES-related disparities are imperative to provide equitable care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17529-w","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:06:24Z","timestamp":1748862384000},"page":"8644-8655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards"],"prefix":"10.1245","volume":"32","author":[{"given":"Kristen M.","family":"HoSang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Bleicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine A.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill R.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"issue":"2","key":"17529_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12013-014-0459-6","volume":"72","author":"Z Tao","year":"2015","unstructured":"Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333\u20138.","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"17529_CR2","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341.","journal-title":"CA Cancer J Clin"},{"key":"17529_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.breast.2021.08.003","volume":"59","author":"O Bhattacharyya","year":"2021","unstructured":"Bhattacharyya O, Li Y, Fisher JL, Tsung A, Eskander MF, Hamad A, et al. Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients. Breast. 2021;59:314\u201320.","journal-title":"Breast"},{"issue":"7","key":"17529_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jnci\/94.7.490","volume":"94","author":"CJ Bradley","year":"2002","unstructured":"Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"17529_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1353\/hpu.2014.0050","volume":"25","author":"SM Monnat","year":"2014","unstructured":"Monnat SM. Race\/ethnicity and the socioeconomic status gradient in women\u2019s cancer screening utilization: a case of diminishing returns? J Health Care Poor Underserved. 2014;25(1):332\u201356.","journal-title":"J Health Care Poor Underserved"},{"key":"17529_CR6","unstructured":"Surgeons ACo. National Accreditation Program for Breast Centers. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-accreditation-program-for-breast-centers\/"},{"issue":"5","key":"17529_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1524-4741.2008.00639.x","volume":"14","author":"DP Winchester","year":"2008","unstructured":"Winchester DP. The national accreditation program for breast centers: a multidisciplinary approach to improve the quality of care for patients with diseases of the breast. Breast J. 2008;14(5):409\u201311.","journal-title":"Breast J"},{"issue":"10","key":"17529_CR8","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1245\/s10434-021-10451-x","volume":"28","author":"AD Williams","year":"2021","unstructured":"Williams AD, Ciocca R, Sabol JL, Carp NZ. Institutions treating breast cancer patients of a low socioeconomic status achieve multidisciplinary quality standards at lower rates. Ann Surg Oncol. 2021;28(10):5635\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"17529_CR9","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","volume":"3","author":"DJ Boffa","year":"2017","unstructured":"Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722\u20138.","journal-title":"JAMA Oncol."},{"issue":"6","key":"17529_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","volume":"26","author":"K Mallin","year":"2019","unstructured":"Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, et al. Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012\u20132014. Ann Surg Oncol. 2019;26(6):1604\u201312.","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"17529_CR11","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMp2114767","volume":"385","author":"DB White","year":"2021","unstructured":"White DB, Villarroel L, Hick JL. Inequitable access to hospital care\u2013protecting disadvantaged populations during public health emergencies. N Engl J Med. 2021;385(24):2211\u20134.","journal-title":"N Engl J Med."},{"issue":"4","key":"17529_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10754-020-09284-0","volume":"20","author":"M Rosko","year":"2020","unstructured":"Rosko M, Al-Amin M, Tavakoli M. Efficiency and profitability in US not-for-profit hospitals. Int J Health Econ Manag. 2020;20(4):359\u201379.","journal-title":"Int J Health Econ Manag"},{"key":"17529_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.socscimed.2015.12.002","volume":"150","author":"EG Liberati","year":"2016","unstructured":"Liberati EG, Gorli M, Scaratti G. Invisible walls within multidisciplinary teams: disciplinary boundaries and their effects on integrated care. Soc Sci Med. 2016;150:31\u20139.","journal-title":"Soc Sci Med"},{"key":"17529_CR14","unstructured":"Kaplan A, O\u2019Neill D. Hospital price discrimination is deepening racial health inequity. NEJM Catalyst [Internet]. 2020."},{"key":"17529_CR15","doi-asserted-by":"publisher","first-page":"102911","DOI":"10.1016\/j.healthplace.2022.102911","volume":"78","author":"N Nwana","year":"2022","unstructured":"Nwana N, Chan W, Langabeer J, Kash B, Krause TM. Does hospital location matter? Association of neighborhood socioeconomic disadvantage with hospital quality in US metropolitan settings. Health Place. 2022;78:102911.","journal-title":"Health Place."},{"issue":"5","key":"17529_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamaoncol.2021.7987","volume":"8","author":"SMQ Hussaini","year":"2022","unstructured":"Hussaini SMQ, Gupta A, Dusetzina SB. Financial toxicity of cancer treatment. JAMA Oncol. 2022;8(5):788.","journal-title":"JAMA Oncol"},{"issue":"2","key":"17529_CR17","doi-asserted-by":"publisher","first-page":"e2255388","DOI":"10.1001\/jamanetworkopen.2022.55388","volume":"6","author":"AN Ehsan","year":"2023","unstructured":"Ehsan AN, Wu CA, Minasian A, Singh T, Bass M, Pace L, et al. Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(2):e2255388.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"17529_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-022-02260-0","volume":"20","author":"KA Hirko","year":"2022","unstructured":"Hirko KA, Rocque G, Reasor E, Taye A, Daly A, Cutress RI, et al. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology. BMC Med. 2022;20(1):72.","journal-title":"BMC Med"},{"key":"17529_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-20301-6_3","volume":"1152","author":"CG Yedjou","year":"2019","unstructured":"Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, et al. Health and racial disparity in breast cancer. Adv Exp Med Biol. 2019;1152:31\u201349.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"17529_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s11606-022-07562-w","volume":"38","author":"G Himmelstein","year":"2023","unstructured":"Himmelstein G, Ceasar JN, Himmelstein KE. Hospitals that serve many Black patients have lower revenues and profits: structural racism in hospital financing. J Gen Intern Med. 2023;38(3):586\u201391.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"17529_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1158\/1055-9965.EPI-17-0945","volume":"28","author":"RB Warnecke","year":"2019","unstructured":"Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH. Multilevel examination of health disparity: the role of policy implementation in neighborhood context, in patient resources, and in healthcare facilities on later stage of breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2019;28(1):59\u201366.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"17529_CR22","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/MLR.0000000000000417","volume":"53","author":"Y Molina","year":"2015","unstructured":"Molina Y, Silva A, Rauscher GH. Racial\/ethnic disparities in time to a breast cancer diagnosis: the mediating effects of health care facility factors. Med Care. 2015;53(10):872\u20138.","journal-title":"Med Care."},{"key":"17529_CR23","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i4.3814","author":"T Jones","year":"2023","unstructured":"Jones T, Wisdom-Chambers K, Freeman K, Edwards K. Barriers to mammography screening among black women at a community health center in south Florida, USA. Med Res Arch. 2023. https:\/\/doi.org\/10.18103\/mra.v11i4.3814.","journal-title":"Med Res Arch"},{"issue":"1","key":"17529_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12609-023-00473-7","volume":"15","author":"AD Williams","year":"2023","unstructured":"Williams AD, Moo T-A. The impact of socioeconomic status and social determinants of health on disparities in breast cancer incidence, treatment, and outcomes. Current Breast Cancer Rep. 2023;15(1):30\u20136.","journal-title":"Current Breast Cancer Rep"},{"key":"17529_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2020.03.063","volume":"254","author":"A Nayyar","year":"2020","unstructured":"Nayyar A, Strassle PD, Schlottmann F, Jadi J, Moses CG, Black JA, et al. Disparities in the use of sentinel lymph node dissection for early stage breast cancer. J Surg Res. 2020;254:31\u201340.","journal-title":"J Surg Res"},{"issue":"2","key":"17529_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10549-018-4909-5","volume":"172","author":"AK Green","year":"2018","unstructured":"Green AK, Aviki EM, Matsoukas K, Patil S, Korenstein D, Blinder V. Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2018;172(2):247\u201363.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"17529_CR27","first-page":"122","volume":"17","author":"L Du Xianglin","year":"2007","unstructured":"Du Xianglin L, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17(1):122\u20138.","journal-title":"Ethn Dis."},{"issue":"12","key":"17529_CR28","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","volume":"3","author":"D Huo","year":"2017","unstructured":"Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, et al. Comparison of breast cancer molecular features and survival by african and european ancestry in the cancer genome atlas. JAMA Oncol. 2017;3(12):1654\u201362.","journal-title":"JAMA Oncol."},{"issue":"3","key":"17529_CR29","first-page":"221","volume":"65","author":"B Daly","year":"2015","unstructured":"Daly B, Olopade OI. A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221\u201338.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"17529_CR30","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1097\/SLA.0000000000005004","volume":"274","author":"N Goel","year":"2021","unstructured":"Goel N, Yadegarynia S, Lubarsky M, Choi S, Kelly K, Balise R, et al. Racial and ethnic disparities in breast cancer survival: emergence of a clinically distinct hispanic black population. Ann Surg. 2021;274(3):e269\u201375.","journal-title":"Ann Surg."},{"issue":"1","key":"17529_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-018-4881-0","volume":"172","author":"A Parekh","year":"2018","unstructured":"Parekh A, Fu W, Hu C, Shen CJ, Alcorn S, Rao AD, et al. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database. Breast Cancer Res Treat. 2018;172(1):201\u20138.","journal-title":"Breast Cancer Res Treat."},{"issue":"5","key":"17529_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11912-024-01514-9","volume":"26","author":"M Chen","year":"2024","unstructured":"Chen M, Wu VS, Falk D, Cheatham C, Cullen J, Hoehn R. Patient navigation in cancer treatment: a systematic review. Curr Oncol Rep. 2024;26(5):504\u201337.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"17529_CR33","doi-asserted-by":"publisher","first-page":"e238908","DOI":"10.1001\/jamanetworkopen.2023.8908","volume":"6","author":"N Goel","year":"2023","unstructured":"Goel N, Hernandez A, Thompson C, Choi S, Westrick A, Stoler J, et al. Neighborhood disadvantage and breast cancer-specific survival. JAMA Netw Open. 2023;6(4):e238908.","journal-title":"JAMA Netw Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17529-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17529-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:39:52Z","timestamp":1760715592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17529-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["17529"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17529-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Austin Williams: Consultant\u2013Elucent Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}